CytRx Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
38,568.10
77,840.50
57,296.80
56,959.50
37,643.40
21,373.30
Total Accounts Receivable
126.00
2,123.90
4,621.60
183.70
7,529.00
148.50
Other Current Assets
2,329.70
3,250.40
2,373.70
3,434.20
1,914.10
994.30
Total Current Assets
41,023.80
83,214.80
64,292.10
60,577.40
47,086.50
22,516.10
Net Property, Plant & Equipment
175.50
970.90
1,467.70
1,959.70
1,042.90
44.30
Intangible Assets
183.80
183.80
183.80
183.80
183.80
-
Other Assets
117.00
1,323.20
1,080.90
48.90
34.30
365.50
Total Assets
41,500.10
85,692.60
67,024.40
62,769.80
48,347.50
22,926
ST Debt & Current Portion LT Debt
-
-
-
5,481.70
10,599.80
Accounts Payable
3,853.50
-
8,058.60
6,406.40
4,122.00
Other Current Liabilities
26,985.20
17,781.10
14,886.80
7,619.90
15,480.70
Total Current Liabilities
30,838.70
17,781.10
22,945.40
19,508.00
30,202.50
Long-Term Debt
-
-
-
18,484.50
-
Total Liabilities
30,838.70
17,781.10
22,945.40
37,992.50
30,202.50
Common Equity (Total)
10,661.40
67,911.50
44,079.00
24,259.30
18,145.10
Total Shareholders' Equity
10,661.40
67,911.50
44,079.00
24,777.30
18,145.10
Total Equity
10,661.40
67,911.50
44,079.00
24,777.30
18,145.10
Liabilities & Shareholders' Equity
41,500.10
85,692.60
67,024.40
62,769.80
48,347.50
Preferred Stock (Carrying Value)
-
-
-
518.00
-

About CytRx

View Profile
Address
11726 San Vicente Boulevard
Los Angeles California 90049
United States
Employees -
Website http://www.cytrx.com
Updated 07/08/2019
CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. It focuses on discovering, developing, and commercializing new therapeutics to treat patients with cancer; including aldoxorubicin, a modified version of the widely-used chemotherapeutic agent, doxorubicin. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.